Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes regarding the study of REL-1017 for Major Depressive Disorder, including the removal of detailed study descriptions and the addition of a new revision number.SummaryDifference13%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 11, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.5%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check80 days agoChange DetectedThe webpage has updated its date references, removing older dates and adding new ones, indicating a refresh of the content. The phrase 'Last Update Posted' has also been modified to include an estimated date.SummaryDifference0.9%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.